Ascelia Pharma AB: ifrs:FinanceCosts
| Value | {"amount": 3965000.0} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Ascelia Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:58:32.725583+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/c79408d2-7b84-4bce-b625-bcb03041ced7
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:5493002YR9VCJJPWYN08:2023-12-31Retrieved: 2026-08-23T23:58:32.725583+02:00
Raw response sha256:
77955d91bfae34156c9ed34b7e96e25e…Cite as: FACTANKER, https://factanker.com/fact/c79408d2-7b84-4bce-b625-bcb03041ced7
History
- no predecessors — first report